Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P RICHARD

Showing results (821-830 of 939) with videos related to

Pageof 94
Sort By:
Scientific Reports|February 26, 2015
Reliable genotypic tropism tests for the major HIV-1 subtypesKieran Cashin, Lachlan R Gray, Katherine L Harvey, et al.
Aging Cell|August 14, 2019
Mitochondrial DNA somatic mutation burden and heteroplasmy are associated with chronological age, smoking, and HIV infectionAdam S Ziada, Meng Ying Lu, Jarek Ignas-Menzies, et al.
Molecular Metabolism|August 24, 2021
LEAP2 deletion in mice enhances ghrelin's actions as an orexigen and growth hormone secretagogueKripa Shankar, Nathan P Metzger, Omprakash Singh, et al.
CJEM|March 19, 2016
Paramedics assessing Elders at Risk for Independence Loss (PERIL): Derivation, Reliability and Comparative Effectiveness of a Clinical Prediction RuleJacques S Lee, P Richard Verbeek, Michael J Schull, et al.
The New England Journal of Medicine|March 15, 2002
Changes in mitochondrial DNA as a marker of nucleoside toxicity in HIV-infected patientsHélène C F Côté, Zabrina L Brumme, Kevin J P Craib, et al.
Viruses|August 28, 2021
SHARED: An International Collaboration to Unravel Hepatitis C ResistanceAnita Y M Howe, Francesca Ceccherini-Silberstein, Julia Dietz, et al.
Molecular Metabolism|May 23, 2021
Disrupting the ghrelin-growth hormone axis limits ghrelin's orexigenic but not glucoregulatory actionsDeepali Gupta, Anna M Patterson, Sherri Osborne-Lawrence, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 26, 2012
Population-based sequencing of the V3-loop can predict the virological response to maraviroc in treatment-naive patients of the MERIT trialRachel A McGovern, Alexander Thielen, Simon Portsmouth, et al.
The Journal of Infectious Diseases|February 4, 2011
Deep sequencing to infer HIV-1 co-receptor usage: application to three clinical trials of maraviroc in treatment-experienced patientsLuke C Swenson, Theresa Mo, Winnie W Y Dong, et al.
AIDS (London, England)|April 20, 2004
Clinical and immunological impact of HIV envelope V3 sequence variation after starting initial triple antiretroviral therapyZabrina L Brumme, Winnie W Y Dong, Benita Yip, et al.
Pageof 94

Showing results (821-830 of 939) with videos related to

Sort By:
Pageof 94
Scientific Reports|February 26, 2015
Reliable genotypic tropism tests for the major HIV-1 subtypesKieran Cashin, Lachlan R Gray, Katherine L Harvey, et al.
Aging Cell|August 14, 2019
Mitochondrial DNA somatic mutation burden and heteroplasmy are associated with chronological age, smoking, and HIV infectionAdam S Ziada, Meng Ying Lu, Jarek Ignas-Menzies, et al.
Molecular Metabolism|August 24, 2021
LEAP2 deletion in mice enhances ghrelin's actions as an orexigen and growth hormone secretagogueKripa Shankar, Nathan P Metzger, Omprakash Singh, et al.
CJEM|March 19, 2016
Paramedics assessing Elders at Risk for Independence Loss (PERIL): Derivation, Reliability and Comparative Effectiveness of a Clinical Prediction RuleJacques S Lee, P Richard Verbeek, Michael J Schull, et al.
The New England Journal of Medicine|March 15, 2002
Changes in mitochondrial DNA as a marker of nucleoside toxicity in HIV-infected patientsHélène C F Côté, Zabrina L Brumme, Kevin J P Craib, et al.
Viruses|August 28, 2021
SHARED: An International Collaboration to Unravel Hepatitis C ResistanceAnita Y M Howe, Francesca Ceccherini-Silberstein, Julia Dietz, et al.
Molecular Metabolism|May 23, 2021
Disrupting the ghrelin-growth hormone axis limits ghrelin's orexigenic but not glucoregulatory actionsDeepali Gupta, Anna M Patterson, Sherri Osborne-Lawrence, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 26, 2012
Population-based sequencing of the V3-loop can predict the virological response to maraviroc in treatment-naive patients of the MERIT trialRachel A McGovern, Alexander Thielen, Simon Portsmouth, et al.
The Journal of Infectious Diseases|February 4, 2011
Deep sequencing to infer HIV-1 co-receptor usage: application to three clinical trials of maraviroc in treatment-experienced patientsLuke C Swenson, Theresa Mo, Winnie W Y Dong, et al.
AIDS (London, England)|April 20, 2004
Clinical and immunological impact of HIV envelope V3 sequence variation after starting initial triple antiretroviral therapyZabrina L Brumme, Winnie W Y Dong, Benita Yip, et al.
Pageof 94